Larsson L J, Neuenschwander D E, Strickland D K
Biochemistry Laboratory, American Red Cross, Biomedical Research and Development, Rockville, Maryland 20855.
Biochemistry. 1989 Sep 19;28(19):7636-43. doi: 10.1021/bi00445a020.
Titration experiments were employed to measure the binding stoichiometry of alpha 2M for trypsin at high and low concentrations of reactants. These titration experiments were performed by measuring the SBTI-resistant trypsin activity and by direct binding measurements using 125I-labeled trypsin. The binding stoichiometry displayed a marked dependence upon protein concentration. At high alpha 2M concentrations (micromolar), 2 mol of trypsin are bound/mol of inhibitor. However, at low alpha 2M concentrations (e.g., 0.5 nM), only 1.3 mol of trypsin were bound/mol of inhibitor. Sequential additions of subsaturating amounts of trypsin to a single aliquot of alpha 2M also resulted in a reduction in the final binding ratio. A model has been formulated to account for these observations. A key element of this model is the observation that purified 1:1 alpha 2M-proteinase complexes are not capable of binding a full mole of additional proteinase [Strickland et al. (1988) Biochemistry 27, 1458-1466]. The model predicts that once the 1:1 alpha 2M-proteinase complex forms, this species undergoes a time-dependent conformational rearrangement to yield a complex with greatly reduced proteinase binding ability. According to this model, the ability of alpha 2M to bind 2 mol of proteinase depends upon the association rate of the second enzyme molecule with the binary (1:1) complex, the enzyme concentration, and the rate of the conformational alteration that occurs once the initial complex forms. Modeling experiments suggest that the magnitude of the rate constant for this conformational change is in the order of 1-2 s-1.
采用滴定实验来测定在反应物高浓度和低浓度条件下α2M与胰蛋白酶的结合化学计量比。这些滴定实验通过测量对大豆胰蛋白酶抑制剂(SBTI)具有抗性的胰蛋白酶活性以及使用125I标记的胰蛋白酶进行直接结合测量来进行。结合化学计量比显示出对蛋白质浓度的显著依赖性。在高α2M浓度(微摩尔级)下,每摩尔抑制剂结合2摩尔胰蛋白酶。然而,在低α2M浓度(例如0.5 nM)下,每摩尔抑制剂仅结合1.3摩尔胰蛋白酶。向一份α2M中依次加入不饱和量的胰蛋白酶也导致最终结合比降低。已建立一个模型来解释这些观察结果。该模型的一个关键要素是观察到纯化的1:1 α2M - 蛋白酶复合物不能再结合一整摩尔额外的蛋白酶[斯特里克兰等人(1988年)《生物化学》27卷,第1458 - 1466页]。该模型预测,一旦1:1 α2M - 蛋白酶复合物形成,这个复合物会经历一个时间依赖性的构象重排,从而产生一个蛋白酶结合能力大大降低的复合物。根据这个模型,α2M结合2摩尔蛋白酶的能力取决于第二个酶分子与二元(1:1)复合物的缔合速率、酶浓度以及初始复合物形成后发生的构象改变速率。模拟实验表明,这种构象变化的速率常数大小约为1 - 2 s-1。